Collegium Pharmaceutical Inc.

COLL | NASDAQ

Price Alert Chart Builder DCF Calculator

$23.15

+$0.11 (+0.48%)

Sep 22, 2026, 12:04 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	780.57M	631.45M	566.77M	463.93M	276.87M	310.02M
Cost of Revenue	317.31M	254.11M	240.6M	254.45M	126.25M	130.18M
Gross Profit	463.26M	377.34M	326.17M	209.49M	150.62M	179.84M
Operating Income	187.08M	169.9M	166.96M	33.32M	17.63M	56.23M
Interest Income	11.29M	13.98M	15.62M	1.05M	12K	232K
Pretax Income	92.62M	98.57M	75.73M	-28.85M	-3.37M	27.58M
Net Income	62.87M	69.19M	48.16M	-25M	71.52M	26.75M
Selling & General & Admin	276.17M	182.98M	159.21M	172.19M	118.96M	113.83M
Research & Development	n/a	n/a	n/a	3.98M	9.45M	9.77M
Other Expenses	n/a	24.47M	n/a	n/a	4.58M	n/a
Operating Expenses	276.17M	207.45M	159.21M	176.17M	132.99M	123.6M
Interest Expense	82.31M	73.97M	83.34M	63.21M	21.01M	28.88M
Selling & Marketing Expenses	n/a	10.66M	n/a	n/a	n/a	n/a
Cost & Expenses	593.48M	461.55M	399.81M	430.61M	259.24M	253.78M
Income Tax Expense	29.75M	29.38M	27.58M	-3.85M	-74.89M	830K
Shares Outstanding (Basic)	31.71M	32.27M	33.74M	33.83M	34.94M	34.41M
Shares Outstanding (Diluted)	39.7M	40.42M	41.79M	33.83M	41.05M	35.15M
EPS (Basic)	1.98	2.14	1.60	-0.74	2.05	0.78
EPS (Diluted)	1.73	1.86	1.29	-0.74	1.86	0.76
EBITDA	401.01M	341.7M	308.33M	173.31M	86.56M	118.01M
EBIT	174.93M	172.54M	159.07M	34.37M	17.64M	56.46M
Depreciation & Amortization	226.07M	169.16M	149.26M	138.94M	68.92M	61.55M